Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 20
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02846324 | Study to Evaluate the Safety and Tolerability of GBT440 Administered to Subjects With IPF | ||
| NCT03051711 | Study to Evaluate Effects of Investigational Drug on Oxygenation in Healthy Volunteers Under Hypoxic Conditions | ||
| NCT02567695 | A Single-Dose Relative Bioavailability Study Of GBT440 300 mg Capsules in Healthy Subjects | ||
| NCT05780541 | PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial) | ||
| NCT04501978 | ACTIV-3: Therapeutics for Inpatients With COVID-19 | ||
| NCT02567682 | Drug Interaction Study of GBT440 With Caffeine, S-warfarin, Omeprazole, and Midazolam in Healthy Subjects | ||
| NCT05780437 | AZD7442 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial) | ||
| NCT03041909 | An Extension Study to Further Evaluate the Safety, Tolerability of GBT440 in Patients With Sickle Cell Disease Who Participated in the Study GBT440-001 | ||
| NCT05780281 | VIR-7831 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial) | ||
| NCT04581356 | Voxelotor Sickle Cell Exercise Study | ||
| NCT04335721 | A Voxelotor for Sickle Cell Anemia Patients at Highest Risk for Progression of Chronic Kidney Disease | ||
| NCT03161015 | Single-Dose PK Study of GBT440 in Subjects With Renal Impairment | ||
| NCT02285088 | A Study of the Safety, Blood Levels and Biological Effects of GBT440 in Healthy Subjects and Subjects With Sickle Cell Disease | ||
| NCT02989168 | Study to Evaluate the Effect of GBT440 Administered to Subjects With IPF on Supplemental Oxygen at Rest | ||
| NCT05780463 | MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial) | ||
| NCT04843761 | ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19 | ||
| NCT05780268 | LY3819253 (LY-CoV555) for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial) | ||
| NCT04969250 | Vaccination for Recovered Inpatients With COVID-19 (VATICO) | ||
| NCT05780424 | BRII-196/BRII-198 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial) | ||
| NCT02497924 | A Study of the Absorption, Metabolism, and Excretion of GBT440 in Healthy Male Subjects |
